Cephalexin - CAS 15686-71-2
Catalog number:
15686-71-2
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C16H17N3O4S
Molecular Weight:
347.39
COA:
Inquire
Targets:
Antibacterial
Description:
Cephalexin increases the activity of superficial mucous cells and orifice mucous cells of gastric glands, and inhibits the activity of cervix mucous cells.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98%
Synonyms:
Cefalexin
MSDS:
Inquire
1. Complexants for the clathration mediated synthesis of the antibiotic cephradine
G. J. Kemperman, R. de Gelder, F. J. Dommerholt, C. G. P. H. Schroën, R. Bosma, and B. Zwanenburg*. Green Chemistry, 2001, 3, 189–192
These three compounds only show reversible inhibition and do not permanently inactivate the enzyme. This implies that the enzyme can be reused for next batches when exposed to either of these three compounds. This is an important observation as the enzyme accounts for a substantial part of the total cost of enzymatically prepared cephalosporins. It should be noted that compounds 1 and 3 are also effective in the complexation with Cephalexin and accordingly also suitable for the clathration mediated enzymatic synthesis of this antibiotic. In Table 3 the residual activity of Assemblase when exposed to either of the three complexing agents as a percentage of the enzyme activity in the absence of complexing agent is listed. These residual activities are similar to those measured after exposure toβ-naphthol, a naphthalene derivative that has a significant beneficial effect on the yield of the enzymatic synthesis of Cephalexin.12 Although a lower enzyme activity on itself is not desirable, it has the advantageous effect that it diminishes the diffusion limitations of Assemblase. This effect was observed for the enzymatic synthesis of Cephalexin using in situ clathration with β-naphthol and has been described in a quantitative manner using models developed for Assemblase and free Penicillin G acylase.
2. Structural elucidation of SrtA enzyme in Enterococcus faecalis: an emphasis on screening of potential inhibitors against the biofilm formation
Chandrabose Selvaraj, Jeyachandran Sivakamavalli, Baskaralingam Vaseeharan, Poonam Singhc and Sanjeev Kumar Singh*. Mol. BioSyst., 2014, 10, 1775--1789
This approach combines in an iterative fashion of ligand docking techniques with those for modeling receptor conformational changes. Results of IFD are illustrated in Table 1 (best 5 compounds), which clearly show that all the screened compounds have more affinity for SrtA. Most commonly, the amino acid residues of SER1, LEU2, GLU4, GLY5, CYS136, LYS141 and ARG145 are involved in interaction with hit compounds. The best five compounds namely amoxicillin, cefixime, esomeprazole, cephalexin, and losartan show better scoring and interactions. Of all these compounds, Losartan shows comparatively low energetics towards SrtA. Esomeprazole and losartan show three hydrogen bond interactions and other three compounds show very good interactions with the SrtA binding site amino acids. The distance between the protein ligand interactions was found to be satisfactory with a standard level distance of 1.6–2.4 Å (Table 2). Amoxicillin, cefixime and cephalexin compounds have more than five hydrogen bonds for interaction and the IFD score was found to be -331.10, -330.94 and -328.72, respectively. The esomeprazole and losartan ligands showed only three H-bonds that interact with the receptor and the IFD score was -330.05 and -327.54, respectively.
3. Siderophore-dependent iron uptake systems as gates for antibiotic Trojan horse strategies against Pseudomonas aeruginosa
Gaetan L. A. Mislin and Isabelle J. Schalk*. Metallomics, 2014, 6,408—420
In a second approach, the same group purified the PVD produced by P. aeruginosa ATCC 15692, for the preparation of conjugates with cephalexin, another beta-lactam antibiotic. For this purpose, the arginine side chain of the chromopeptide was crosslinked with N-4,6-dioxoheptanoyl-cephalexin under buffered conditions. The resulting pyrimidine linker was described as stable in biological medium. The PVD–cephalexin conjugate 12 (PDPyrCeph) (Fig. 6) was tested against bacteria and was found to have no activity against P. aeruginosa ATCC 15692.
4. One-step synthesis of carbon nanodots for sensitive detection of cephalexin
Kunjie Wang, Feng Guan, Hongxia Li,* Mingliang Li, Huixia Fenga and Haiyan Fan*. RSC Adv.,2015, 5,20511–20515
Cephalexin is a lactam antibiotic which is widely used to treat infections of the urinary tract, the upper respiratory tract, the skin, the middle ear and other common bacterial infections. Despite its efficiency, excessive use of cephalexin is extremely harmful to the human body, for example, it is well known that excessive use of cephalexin will cause acute renal failure in humans and experimental animals. Therefore, developing effective analytical methods for the sensitive and selective detection of trace amounts of cephalexin is especially important. Compared with many other methods, like high-performance liquid chromatography (HPLC), liquid chromatography (LC), flow injection analysis, electrochemical methods, fluorescence assays have several advantages, such as high sensitivity and fast analysis. However, to the best of our knowledge, the use of fluorescence probe for analysis of cephalexin is very rare. Lately, Li et al. proposed a fluorescence probe based on the fluorescence quenching of L-Cysteine capped core–shell CdTe/ZnS nanoparticles to detect cephalexin. The above photoluminescence material suffer from complex synthesis route and expensive regents. Accordingly, the development of a simple, economical, and green preparative strategy toward photoluminescence materials is meaningful.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Antibacterial Products


CAS 873857-62-6 Fidaxomicin

Fidaxomicin
(CAS: 873857-62-6)

Fidaxomicin(OPT-80; PAR-101) is a new class of narrow spectrum macrocyclic antibiotic drug; selective eradication of pathogenic Clostridium difficile with minim...

CAS 888032-58-4 WQ3810

WQ3810
(CAS: 888032-58-4)

WQ3810 is a newly developed fluoroquinolone withunique substituents at the N1 and C7 positions of the quinolone ringfor the treatment of antibiotic-resistant in...

CAS 127-69-5 Sulfisoxazole

Sulfisoxazole
(CAS: 127-69-5)

Sulfisoxazole is a sulfonamide antibacterial with an oxazole substituent.

CAS 136212-91-4 Dermaseptin

Dermaseptin
(CAS: 136212-91-4)

Dermaseptin is a 34-residue antimicrobial peptide.

CAS 115550-35-1 Marbofloxacin

Marbofloxacin
(CAS: 115550-35-1)

Marbofloxacin exhibits high bactericidal activity against a broad spectrum of aerobic Gram-negative and some Gram-positive bacteria, as well as Mycoplasma spp.

CAS 78110-38-0 Aztreonam

Aztreonam
(CAS: 78110-38-0)

Aztreonam inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking. It has a very high affinity for penicillin-bin...

CAS 1135871-27-0 Tigecycline mesylate

Tigecycline mesylate
(CAS: 1135871-27-0)

Tigecycline mesylate a first-in-class, broad spectrum antibiotic with activity against antibiotic-resistant organisms.

CAS 122841-10-5 Cefoselis

Cefoselis
(CAS: 122841-10-5)

Cefoselis, a new parenteral cephalosporin, was active against clinical isolates of both gram-positive and gram-negative aerobic bacteria. The activity of Cefose...

CAS 210353-53-0 Gemifloxacin Mesylate

Gemifloxacin Mesylate
(CAS: 210353-53-0)

Gemifloxacin Mesylate,a fluoroquinolone, is an oral broad-spectrum antibacterial agent that show great in vitro activity against a wide variety of respiratory t...

CAS 151096-09-2 Moxifloxacin

Moxifloxacin
(CAS: 151096-09-2)

Moxifloxacin is an extended-spectrum fluoroquinolone which has improved coverage against gram-positive cocci and atypical pathogens compared with older fluoroqu...

CAS 147-52-4 Nafcillin

Nafcillin
(CAS: 147-52-4)

Nafcillin, a semi-synthetic penicillin analogue, has been found to be an antibiotic that could be effective especially against Gram-positive bacteria.

CAS 131-69-1 Phthalylsulfacetamide

Phthalylsulfacetamide
(CAS: 131-69-1)

Phthalylsulfacetamide, a sulfanilamide derivative, is a predrug of sulfacetamide and could be used as an antibacterial agent.

CAS 24168-96-5 Isoconazole nitrate

Isoconazole nitrate
(CAS: 24168-96-5)

Isoconazole nitrate (Travogen) is an azole antifungal reagent.Nigerian and British medical researchers found that for foot and vaginal infections, isoconazole h...

CAS 74-55-5 Ethambutol

Ethambutol
(CAS: 74-55-5)

Ethambutol is a bacteriostatic antimycobacterial agent, which obstructs the formation of cell wall by inhibiting arabinosyl transferases. lt directly affects tw...

CAS 21736-83-4 Spectinomycin Hydrochloride

Spectinomycin Hydrochloride
(CAS: 21736-83-4)

Spectinomycin is an antibiotic useful for the treatment of the bacterial infection, gonorrhea.It is marketed as the hydrochloride salt spectinomycin hydrochlori...

CAS 74610-55-2 Tylosin tartrate

Tylosin tartrate
(CAS: 74610-55-2)

Tylosin tartrate is a macrolide antibiotic approved for the control of mycoplasmosis in poultry.

CAS 1404-93-9 Vancomycin HCl

Vancomycin HCl
(CAS: 1404-93-9)

Vancomycin HCl is a hydrochloride of vancomycin that is a narrow-spectrum glycopeptide antibacterial agent.

CAS 3116-76-5 Dicloxacillin

Dicloxacillin
(CAS: 3116-76-5)

Dicloxacillin, a β-lactamase resistant penicillin similar to oxacillin, used to treat infections caused by susceptible (non-resistant) Gram-positive bacteria.

CAS 4936-47-4 Nifuratel

Nifuratel
(CAS: 4936-47-4)

Nifuratel is a broad antibacterial spectrum agent, which is used as an antibacterial, antifungal, and antiprotozoal.

CAS 651-06-9 Sulfameter

Sulfameter
(CAS: 651-06-9)

Sulfameter is a long-acting sulfonamide antibacterial. It is used as a leprostatic agent and in the treatment of urinary tract infections.

Chemical Structure

CAS 15686-71-2 Cephalexin

Quick Inquiry

Verification code

Featured Items